A detailed history of Signaturefd, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,663 shares of NUVB stock, worth $3,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,663
Previous 1,126 47.69%
Holding current value
$3,675
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$2.3 - $3.83 $1,235 - $2,056
537 Added 47.69%
1,663 $3,000
Q4 2023

Jan 31, 2024

BUY
$0.96 - $1.53 $1,080 - $1,722
1,126 New
1,126 $1,000
Q1 2023

Apr 28, 2023

SELL
$1.6 - $2.48 $10,128 - $15,698
-6,330 Reduced 87.29%
922 $1,000
Q4 2022

Jan 27, 2023

BUY
$1.68 - $2.5 $7,008 - $10,430
4,172 Added 135.45%
7,252 $13,000
Q3 2022

Nov 08, 2022

BUY
$0.29 - $4.04 $893 - $12,443
3,080 New
3,080 $7,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.